CANCER IMMUNOLOGY. The "cancer immunogram" - PubMed (original) (raw)

. 2016 May 6;352(6286):658-60.

doi: 10.1126/science.aaf2834.

Affiliations

• PMID: 27151852
• DOI: 10.1126/science.aaf2834

Free article

CANCER IMMUNOLOGY. The "cancer immunogram"

Christian U Blank et al. Science. 2016.

Free article

No abstract available

PubMed Disclaimer

Similar articles

• The Cancer Immunogram as a Framework for Personalized Immunotherapy in Urothelial Cancer.
  van Dijk N, Funt SA, Blank CU, Powles T, Rosenberg JE, van der Heijden MS. van Dijk N, et al. Eur Urol. 2019 Mar;75(3):435-444. doi: 10.1016/j.eururo.2018.09.022. Epub 2018 Sep 28. Eur Urol. 2019. PMID: 30274701 Free PMC article. Review.
• Introduction: Cancer Immunology Special Issue-Immunotherapy.
  Kawakami Y. Kawakami Y. Int Immunol. 2016 Jul;28(7):317. doi: 10.1093/intimm/dxw028. Epub 2016 Jun 15. Int Immunol. 2016. PMID: 27313100 No abstract available.
• Regulatory T cells in cancer; can they be controlled?
  Adeegbe DO, Nishikawa H. Adeegbe DO, et al. Immunotherapy. 2015;7(8):843-6. doi: 10.2217/imt.15.52. Epub 2015 Aug 28. Immunotherapy. 2015. PMID: 26316166 No abstract available.
• [Cell therapy in solid tumors].
  Ravaud A. Ravaud A. Bull Cancer. 2001 Jan;88(1):91-100. Bull Cancer. 2001. PMID: 11182658 Review. French. No abstract available.
• Adoptive cellular immunotherapy of cancer.
  Winter H, Fox BA. Winter H, et al. Curr Opin Mol Ther. 1999 Feb;1(1):89-97. Curr Opin Mol Ther. 1999. PMID: 11249690 Review. No abstract available.

Cited by

• Integrating treatment cost reduction strategies and biomarker research to reduce costs and personalize expensive treatments: an example of a self-funding trial in non-small cell lung cancer.
  Buma AIG, Piet B, Ter Heine R, van den Heuvel MM. Buma AIG, et al. Front Pharmacol. 2023 Nov 28;14:1274532. doi: 10.3389/fphar.2023.1274532. eCollection 2023. Front Pharmacol. 2023. PMID: 38089058 Free PMC article.
• Blood Lymphocytes as a Prognostic Factor for Stage III Non-Small Cell Lung Cancer with Concurrent Chemoradiation.
  Kim YH, Choi YD, Ahn SJ, Kim YC, Oh IJ, Nam TK, Jeong JU, Song JY. Kim YH, et al. Chonnam Med J. 2024 Jan;60(1):40-50. doi: 10.4068/cmj.2024.60.1.40. Epub 2024 Jan 25. Chonnam Med J. 2024. PMID: 38304134 Free PMC article.
• ASCO 2018 NSCLC highlights-combination therapy is key.
  Gamerith G, Kocher F, Rudzki J, Pircher A. Gamerith G, et al. Memo. 2018;11(4):266-271. doi: 10.1007/s12254-018-0444-7. Epub 2018 Oct 22. Memo. 2018. PMID: 30595752 Free PMC article. Review.
• Cell segmentation for immunofluorescence multiplexed images using two-stage domain adaptation and weakly labeled data for pre-training.
  Han W, Cheung AM, Yaffe MJ, Martel AL. Han W, et al. Sci Rep. 2022 Mar 15;12(1):4399. doi: 10.1038/s41598-022-08355-1. Sci Rep. 2022. PMID: 35292693 Free PMC article.
• The Cancer Immunogram as a Framework for Personalized Immunotherapy in Urothelial Cancer.
  van Dijk N, Funt SA, Blank CU, Powles T, Rosenberg JE, van der Heijden MS. van Dijk N, et al. Eur Urol. 2019 Mar;75(3):435-444. doi: 10.1016/j.eururo.2018.09.022. Epub 2018 Sep 28. Eur Urol. 2019. PMID: 30274701 Free PMC article. Review.

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Atypon
  • Ovid Technologies, Inc.
  • eScholarship, California Digital Library, University of California

• Other Literature Sources

  • H1 Connect
  • The Lens - Patent Citations Database
  • scite Smart Citations